SynuCa Therapeutics

Seed
synuca.com Biotech & Healthcare Aarhus, Denmark
Total Funding Undisclosed
Latest Round Undisclosed Seed
Last Announced Mar 2, 2026
Investors Undisclosed
Decision Makers Profile Active

About SynuCa Therapeutics

Synuca Therapeutics focused on developing innovative therapies for neurological disorders, particularly Parkinson's disease.

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Seed
Global Headquarters Aarhus, Denmark
Tracked Since Oct 2, 2026

Web & Domain Identity

Official Website synuca.com
Domain Registered Date Jan 6, 2025

Social & Network Presence

X / Twitter Profile Not linked
LinkedIn Corporate Not linked

Company Milestones & Timeline

2 Events
  1. Capital Raise

    Seed announced

  2. Milestone

    Website domain registered

    synuca.com

Investors & Backers

Investor firms and individual backers were not publicly disclosed in available round filings for SynuCa Therapeutics.

Funding History

1 Round
Seed equity · Mar 2, 2026
Undisclosed

Founders & Leadership

4

Lasse Reimer

CEO/Founder

Work email & phone locked Unlock →

Professor Claus Elsborg Olesen

Founder

Work email & phone locked Unlock →

Professor Poul Henning Jensen

Founder

Work email & phone locked Unlock →

William Dalby Brown

COO/founder

Work email & phone locked Unlock →

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts